Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 19 studies | 85% ± 20% | |
peripheral blood | 19 studies | 91% ± 17% | |
brain | 14 studies | 45% ± 20% | |
intestine | 13 studies | 89% ± 16% | |
eye | 10 studies | 67% ± 22% | |
kidney | 8 studies | 83% ± 20% | |
liver | 7 studies | 68% ± 24% | |
bone marrow | 6 studies | 91% ± 11% | |
pancreas | 5 studies | 87% ± 17% | |
uterus | 5 studies | 94% ± 10% | |
lymph node | 4 studies | 99% ± 1% | |
placenta | 4 studies | 89% ± 18% | |
heart | 4 studies | 43% ± 19% | |
adipose | 4 studies | 44% ± 31% | |
esophagus | 4 studies | 76% ± 22% | |
prostate | 4 studies | 95% ± 9% | |
breast | 4 studies | 97% ± 3% | |
skin | 3 studies | 88% ± 14% | |
stomach | 3 studies | 68% ± 23% | |
thymus | 3 studies | 75% ± 34% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 38015.13 | 1445 / 1445 | 100% | 503.48 | 183 / 183 |
liver | 100% | 17244.32 | 226 / 226 | 100% | 376.21 | 406 / 406 |
ovary | 100% | 80922.62 | 180 / 180 | 100% | 817.81 | 430 / 430 |
pancreas | 100% | 35388.95 | 328 / 328 | 100% | 522.17 | 178 / 178 |
skin | 100% | 46179.37 | 1809 / 1809 | 100% | 455.92 | 472 / 472 |
thymus | 100% | 37036.18 | 653 / 653 | 100% | 585.37 | 604 / 605 |
uterus | 100% | 51703.52 | 170 / 170 | 100% | 655.51 | 458 / 459 |
lung | 100% | 31395.82 | 576 / 578 | 100% | 546.51 | 1155 / 1155 |
stomach | 100% | 32638.38 | 359 / 359 | 100% | 527.71 | 285 / 286 |
brain | 100% | 20040.56 | 2632 / 2642 | 100% | 473.39 | 705 / 705 |
intestine | 100% | 40030.12 | 966 / 966 | 100% | 614.69 | 525 / 527 |
prostate | 100% | 42001.77 | 245 / 245 | 100% | 735.21 | 500 / 502 |
bladder | 100% | 43591.10 | 21 / 21 | 99% | 584.30 | 501 / 504 |
breast | 100% | 48136.62 | 459 / 459 | 99% | 557.69 | 1111 / 1118 |
kidney | 100% | 31038.31 | 89 / 89 | 98% | 414.33 | 886 / 901 |
adrenal gland | 100% | 32189.35 | 258 / 258 | 94% | 353.45 | 216 / 230 |
eye | 0% | 0 | 0 / 0 | 100% | 788.05 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 1431.59 | 29 / 29 |
spleen | 100% | 47195.11 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 550.79 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 450.63 | 1 / 1 |
blood vessel | 100% | 38687.43 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 40318.98 | 1203 / 1204 | 0% | 0 | 0 / 0 |
muscle | 99% | 19564.28 | 792 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 18366.07 | 843 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 86% | 25810.98 | 797 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016567 | Biological process | protein ubiquitination |
GO_0006412 | Biological process | translation |
GO_0019941 | Biological process | modification-dependent protein catabolic process |
GO_0002181 | Biological process | cytoplasmic translation |
GO_0005730 | Cellular component | nucleolus |
GO_0005615 | Cellular component | extracellular space |
GO_0022626 | Cellular component | cytosolic ribosome |
GO_0005886 | Cellular component | plasma membrane |
GO_0022627 | Cellular component | cytosolic small ribosomal subunit |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0032040 | Cellular component | small-subunit processome |
GO_0030666 | Cellular component | endocytic vesicle membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0045202 | Cellular component | synapse |
GO_0005737 | Cellular component | cytoplasm |
GO_0005741 | Cellular component | mitochondrial outer membrane |
GO_0010008 | Cellular component | endosome membrane |
GO_0031982 | Cellular component | vesicle |
GO_0005634 | Cellular component | nucleus |
GO_0031386 | Molecular function | protein tag activity |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0003735 | Molecular function | structural constituent of ribosome |
GO_0046872 | Molecular function | metal ion binding |
GO_0003723 | Molecular function | RNA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | RPS27A |
Protein name | Ubiquitin-ribosomal protein eS31 fusion protein (Ubiquitin carboxyl extension protein 80) RPS27A protein Ubiquitin-40S ribosomal protein S27a Ubiquitin-ribosomal protein eS31 fusion protein (Ubiquitin carboxyl extension protein 80) [Cleaved into: Ubiquitin; Small ribosomal subunit protein eS31 (40S ribosomal protein S27a)] |
Synonyms | UBA80 hCG_1987923 HEL112 UBCEP1 |
Description | FUNCTION: [Ubiquitin]: Exists either covalently attached to another protein, or free (unanchored). When covalently bound, it is conjugated to target proteins via an isopeptide bond either as a monomer (monoubiquitin), a polymer linked via different Lys residues of the ubiquitin (polyubiquitin chains) or a linear polymer linked via the initiator Met of the ubiquitin (linear polyubiquitin chains). Polyubiquitin chains, when attached to a target protein, have different functions depending on the Lys residue of the ubiquitin that is linked: Lys-6-linked may be involved in DNA repair; Lys-11-linked is involved in ERAD (endoplasmic reticulum-associated degradation) and in cell-cycle regulation; Lys-29-linked is involved in proteotoxic stress response and cell cycle; Lys-33-linked is involved in kinase modification; Lys-48-linked is involved in protein degradation via the proteasome; Lys-63-linked is involved in endocytosis, DNA-damage responses as well as in signaling processes leading to activation of the transcription factor NF-kappa-B. Linear polymer chains formed via attachment by the initiator Met lead to cell signaling. Ubiquitin is usually conjugated to Lys residues of target proteins, however, in rare cases, conjugation to Cys or Ser residues has been observed. When polyubiquitin is free (unanchored-polyubiquitin), it also has distinct roles, such as in activation of protein kinases, and in signaling. .; FUNCTION: [Small ribosomal subunit protein eS31]: Component of the 40S subunit of the ribosome . Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate with the nascent pre-rRNA and work in concert to generate RNA folding, modifications, rearrangements and cleavage as well as targeted degradation of pre-ribosomal RNA by the RNA exosome . . |
Accessions | P62979 B2RDW1 Q5RKT7 ENST00000272317.11 ENST00000404735.1 Q8WYN9 J3QTR3 ENST00000449323 Q49A90 ENST00000402285.7 |